How much revenue does Australis Capital make?

Australis Capital reported 717,151 CAD in revenue for fiscal year 2021, up 223.8% from 221,482 CAD in fiscal year 2020. In Q3 2022 revenue was 2.37 million CAD.

What companies are similar to Australis Capital?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Indvr Brands Inc. (CAAOF), New Leaf Ventures Inc (NLVVF), YourWay Cannabis Brands Inc. (YOURF), Corix Bioscience, Inc. (CXBS).

Australis Capital Inc. (AUSAF) Stock

About Australis Capital Inc.

Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.

At a glance

Australis Capital reported revenue of 717,151 CAD for fiscal year 2021, up 223.8% from fiscal year 2020, and net income of -25.26 million CAD. In Q3 2022 (the quarter ended December 31, 2021) revenue was 2.37 million CAD, up 2523.7% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2021.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.